NovoCure Overview
NovoCure Target Price
Analysts' 12-month price predictions for NVCR.
Get informed when a big investor buys or sells
+ FollowShare Price
$17.2
Average Target Price
$46.00
167.4% upside
167.4% upside1 analysts in the last 4 months
High: $46 | Low: $46
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-18 | H.C. WainwrightEmily Bodnar | $46 | 167.4% upside |  |
| 2026-02-12 | H.C. Wainwright | $47 | 173.3% upside | |
| 2026-01-13 | H.C. Wainwright | $39 | 126.7% upside | |
| 2026-01-05 | Evercore ISI | $20 | 16.3% upside | |
| 2025-10-30 | H.C. Wainwright | $42 | 144.2% upside | |
| 2025-07-24 | Wells FargoLarry Biegelsen | $14.5 |  15.7% downside | |
| 2024-12-02 | Evercore ISIVijay Kumar | $30 | 74.4% upside | |
| 2024-10-16 | H.C. WainwrightEmily Bodnar | $30 | 74.4% upside | |
| 2024-07-26 | H.C. WainwrightEmily Bodnar | $24 | 39.5% upside | |
| 2024-05-03 | H.C. WainwrightEmily Bodnar | $22 | 27.9% upside | |
| 2024-05-02 | Evercore ISIVijay Kumar | $14.5 | 15.7% downside | |
| 2024-04-10 | Piper SandlerJason Bednar | $28 | 62.8% upside | |
| 2024-04-03 | Wells FargoLarry Biegelsen | $42 | 144.2% upside | |
| 2024-03-27 | H.C. Wainwright | $24 | 39.5% upside | |
| 2023-01-06 | J.P. Morgan | $99 | 475.6% upside | |
| 2023-01-06 | Wells Fargo | $107 | 522.1% upside | |
| 2023-01-05 | H.C. WainwrightEmily Bodnar | $140 | 714% upside | |
| 2022-11-29 | Wells Fargo | $89 | 417.4% upside | |
| 2022-05-16 | H.C. WainwrightEmily Bodnar | $115 | 568.6% upside | |
| 2022-02-08 | Loop Capital MarketsJason Wittes | $200 | 1062.8% upside | |